SCHEMBL7984975

SCHEMBL7984975

O=c1nc(-c2cccc(C(F)(F)F)c2)[nH]c2ncn(Cc3ccccc3)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.53
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
STAT6 P42226 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974074 0.94 CXCR2 (0.45) CXCR2PARNCNOT7GRIN1GRIN2B
SCHEMBL7988017 0.90 KDM4E (0.43) CXCR2KDM4EMEN1NPC1ALDH1A1
SCHEMBL7987953 0.89 PDE2A (0.46) CXCR2MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL7987255 0.86 PARN (0.48) ALDH1A1CYP1A2CYP3A4CYP2C9HPGD
SCHEMBL7975271 0.86 CNOT7 (0.56) CXCR2ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL7984663 0.85 CNOT7 (0.49) KDM4EMEN1NPC1ALDH1A1HPGD
SCHEMBL7974015 0.85 PARN (0.49) CXCR2ALDH1A1CYP1A2CYP2C9HTT
SCHEMBL7985342 0.84 CNOT7 (0.51) CXCR2ALDH1A1HPGDKMT2ASMN1; SMN2
SCHEMBL7988597 0.84 PARN (0.48) NPC1ALDH1A1PKMHPGDRAB9A
Hydrochloric Acid SCHEMBL7987663 0.84 CNOT7 (0.48) KDM4EMEN1NPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed